Characterization of a single-cycle rabies virus-based vaccine vector.
about
Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccineInduction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathwaysInduction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.An anterograde rabies virus vector for high-resolution large-scale reconstruction of 3D neuron morphologyComparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA VirusesRhabdovirus-based vaccine platforms against henipavirusesSmall-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccineInactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression.A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.Reverse Genetics Approaches to Control Arenavirus.Experimental rabies vaccines for humans.From brain passage to cell adaptation: the road of human rabies vaccine development.RNA-based viral vectors.Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsViral and Synthetic RNA Vector Technologies and Applications.A novel borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region.Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity.Combining confocal and atomic force microscopy to quantify single-virus binding to mammalian cell surfaces.Axonal and subcellular labelling using modified rabies viral vectors.Virus stamping for targeted single-cell infection in vitro and in vivo.
P2860
Q27334697-8519D09D-7E26-4BFA-88D2-B034C9CC1110Q28397551-AE748DE4-7AC3-4EB8-96E7-C9A860970269Q34261441-7AFDE88A-6439-4929-A411-1D3B20D76544Q34414740-B902630A-8DA3-4EBC-A2AE-78A10675F49CQ34806497-7C4D22AF-6157-4B01-80A1-199517000725Q34992537-E749EDE4-2781-47FF-835C-0E4A4C0AD369Q35150964-606E1276-4CF7-4212-B558-B822599EF8BCQ35184639-D7553889-709C-4AC7-B97E-CE7E98E1F811Q35275167-A5F7871D-7FF4-4C68-BEF7-1555F7E301F0Q35803316-5BF4D79B-1D32-447B-AA92-168C1E3E870CQ36210186-B1E34428-8A70-4CE0-A0FB-B77A623397C4Q36312553-4EDB3ACF-8CA0-4300-86E0-62B1770BB610Q36356863-9D81688B-F53F-4416-9EEC-62037C928E6BQ37543755-D3671F13-7F6F-40BA-8C6C-3389945C2839Q37798009-0CE6A320-7120-4CB5-A88A-B8808CA7C1E8Q37951526-5A1AC124-FAA2-4EE6-BAAC-880D86F35567Q38266413-F1AB5D72-25AD-4EDC-9CFE-493477143AA4Q38363535-73776C93-8E89-4B51-BBC1-8691003EA1A7Q38885624-25E1776A-D480-4A29-918B-6DE5C3C940C7Q38960717-7124B081-4E7A-4B02-A7E1-1C44022985EEQ39633419-3E9178FA-AF9D-414E-AAEF-306C3A61375EQ41217724-79CC2A27-4871-45C4-870F-E8354831D0D1Q41923775-3A87F40F-41DA-4DCF-9B74-DBC1B1D839E9Q42276697-0141E3CF-36F0-4C85-8944-ABF1577AD124Q47239972-17F7A7A8-77B6-4B71-BEA4-E71A4013A253
P2860
Characterization of a single-cycle rabies virus-based vaccine vector.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterization of a single-cycle rabies virus-based vaccine vector.
@ast
Characterization of a single-cycle rabies virus-based vaccine vector.
@en
type
label
Characterization of a single-cycle rabies virus-based vaccine vector.
@ast
Characterization of a single-cycle rabies virus-based vaccine vector.
@en
prefLabel
Characterization of a single-cycle rabies virus-based vaccine vector.
@ast
Characterization of a single-cycle rabies virus-based vaccine vector.
@en
P2093
P2860
P356
P1433
P1476
Characterization of a single-cycle rabies virus-based vaccine vector.
@en
P2093
Elizabeth J Faul
Emily A Gomme
James P McGettigan
Matthias J Schnell
Phyllis Flomenberg
P2860
P304
P356
10.1128/JVI.01870-09
P577
2010-01-06T00:00:00Z